Among INSTIs, Dolutegravir decreased the IL-10 levels with a tendency toward statistical significance ( Table 5 ), but this must be carefully interpreted since it reflects only four patients.
← all excerpts
Evaluation of several serum interleukins as markers for treatment effectiveness in naïve HIV infected patients: A pilot study.
1
—
—